# Evonik faces FTC lawsuit to block PeroxyChem acquisition

Evonik's proposed acquisition of PeroxyChem for $625 million is being challenged by the Federal Trade Commission, which will file a lawsuit to block the deal. The acquisition was signed in late 2018 and expected to close by mid-2019.

- Type: Acquisition
- Announced: 2019-08-19
- Where: United States
- Value: $625.0M
- Status: announced
- Products: hydrogen peroxide, peracetic acid
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [One Equity Partners](https://endata.com/companies/710.md) (investor)
- [Evonik](https://endata.com/companies/15139.md) (acquirer)
- [PeroxyChem](https://endata.com/companies/28671.md) (target)

## Sources

- [adhesivesmag.com](https://www.adhesivesmag.com/articles/97148-evonik-closes-sale-of-methacrylates-business-hits-ftc-roadblock-on-peroxychem-acquisition), 2019-08-19: "It is disappointing that the FTC has taken this step to block the acquisition in the highly competitive hydrogen peroxide industry."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.